Callan JMB Inc

CJMB

Market cap $9.75M

GALVESTON, TX / ACCESS Newswire / January 12, 2026 / Callan JMB Inc. (NASDAQ:CJMB), a premier provider of vertically integrated temperature-controlled logistics and specialized life sciences fulfillment, today announced a comprehensive strategic realignment to address the critical infrastructure gap in the global distribution of GLP-1 (glucagon-like peptide-1) medications. As the pharmaceutical industry faces a logistics bottleneck due to the meteoric rise of weight-management and diabetes treatments such as Ozempic®, Wegovy®, and Mounjaro®, Callan JMB is positioning its proprietary cold-chain technology to become the primary "last-mile" fulfillment partner for large-scale telehealth and pharmaceutical distributors.

Move leverages the Company's expertise in regulated materials to capture opportunities in sustainable , high-growth consumer markets

Sentry Monitoring System allows for remote monitoring of refrigerators, freezers, and clean room temperatures for high-value pharmaceutical products in pharmacies, hospitals, and emergency preparedness facilities

SPRING BRANCH, Texas, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced that management will participate in the following September 2025 investment conferences.

Formed a strategic partnership with Revival Health Inc. (“Revival”) to deliver fully integrated supply chain services and infrastructure to support both the importation and onshore manufacturing of health, wellness, and longevity products

Contract Increase Extends Seven-Year Partnership through June 2026 with Price Increase of $1.5 Million to Total Value of $9.1 Million

Callan JMB redistributed more than 1,300 vaccine doses using its specialized cold chain reusable shippers from Westside CDC in Chicago to Texas and New Mexico, ensuring no vaccines went to waste

Completed Initial Public Offering (IPO) on February 6, 2025, at $4.00 per Share for Gross Proceeds of Approximately $5.7 Million, Including Partial Exercise of Over-Allotment Option

Christopher Shields, an industry veteran who oversaw operations and logistics at the city of Chicago's Emergency Preparedness and Bioterrorism program, will focus on growing Callan JMB's emergency preparedness & response operations into new U.S. cities, states, and other countries.

Successfully Closed IPO on February 6, 2025, at $4.00 per Share for Gross Proceeds of Approximately $5.7 Million, Including Partial Exercise of Over-Allotment Option